JPS57500432A
(fi)
*
|
1980-03-20 |
1982-03-11 |
|
|
US4960765A
(en)
*
|
1980-03-20 |
1990-10-02 |
Farmaceutisk Laboratorium Ferring A/S |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
|
SE457505B
(sv)
*
|
1984-01-10 |
1989-01-09 |
Lejus Medical Ab |
Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
|
IL77186A0
(en)
*
|
1985-11-29 |
1986-04-29 |
Touitou Elka |
Pharmaceutical insulin composition
|
GB2196252B
(en)
*
|
1986-09-18 |
1990-10-17 |
London Pharmacy Innovation |
Gastric controlled-release dosage forms
|
GB8707421D0
(en)
*
|
1987-03-27 |
1987-04-29 |
Wellcome Found |
Pharmaceutical formulations
|
JPH01299226A
(ja)
*
|
1988-05-27 |
1989-12-04 |
Seikagaku Kogyo Co Ltd |
サラゾスルファピリジン腸溶顆粒
|
PT93637A
(pt)
*
|
1989-04-20 |
1990-11-20 |
Procter & Gamble |
Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal
|
US5032405A
(en)
*
|
1989-09-27 |
1991-07-16 |
Warner-Lambert Company |
Oral pharmaceutical composition for acid sensitive proteinaceous agents
|
SE8903914D0
(sv)
|
1989-11-22 |
1989-11-22 |
Draco Ab |
Oral composition for the treatment of inflammatory bowel diseases
|
US5643602A
(en)
*
|
1989-11-22 |
1997-07-01 |
Astra Aktiebolag |
Oral composition for the treatment of inflammatory bowel disease
|
JPH05507948A
(ja)
*
|
1990-04-18 |
1993-11-11 |
ユニバーシティ オブ ユタ リサーチ ファウンデーション |
アゾ結合を含み、pH依存性膨潤を示す、架橋したヒドロゲルに基づいた、結腸を標的にした経口薬の投薬形態
|
GB2253346A
(en)
*
|
1991-02-22 |
1992-09-09 |
John Rhodes |
Delayed release oral dosage forms for treatment of intestinal disorders
|
NL9002336A
(nl)
*
|
1990-10-24 |
1992-05-18 |
Leuven K U Res & Dev |
Bekledings- of matrixmateriaal voor geneesmiddelen.
|
US5316772A
(en)
*
|
1990-12-19 |
1994-05-31 |
Solvay & Cie, S.A. (Societe Anonyme) |
Bilayered oral pharmaceutical composition with pH dependent release
|
WO1992016214A1
(en)
*
|
1991-03-15 |
1992-10-01 |
Norwich Eaton Pharmaceuticals Inc. |
The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
|
WO1994010983A1
(en)
*
|
1992-11-06 |
1994-05-26 |
Hisamitsu Pharmaceutical Co., Inc. |
Peroral pharmaceutical preparation releasable in lower digestive tract
|
US5843479A
(en)
*
|
1993-02-26 |
1998-12-01 |
The Procter & Gamble Company |
Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
|
US5914132A
(en)
*
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
US5651983A
(en)
*
|
1993-02-26 |
1997-07-29 |
The Procter & Gamble Company |
Bisacodyl dosage form for colonic delivery
|
PT621032E
(pt)
*
|
1993-04-23 |
2001-01-31 |
Novartis Ag |
Dispositivo de distribuicao de libertacao controlada de farmaco
|
DK66493D0
(da)
*
|
1993-06-08 |
1993-06-08 |
Ferring A S |
Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling
|
US6204243B1
(en)
|
1993-09-01 |
2001-03-20 |
Novatis Ag |
Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
|
US6210714B1
(en)
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
SE9401738D0
(sv)
*
|
1994-05-19 |
1994-05-19 |
Ewos Ab |
Bioactive feed
|
GB2303550B
(en)
*
|
1994-06-21 |
1998-07-08 |
Danbiosyst Uk |
Colonic drug delivery system
|
GB9412394D0
(en)
*
|
1994-06-21 |
1994-08-10 |
Danbiosyst Uk |
Colonic drug delivery composition
|
US5637319A
(en)
*
|
1995-03-01 |
1997-06-10 |
Takada; Kanji |
Controlled-release preparations
|
US6166024A
(en)
*
|
1995-03-30 |
2000-12-26 |
Mayo Foundation For Medical Education And Research |
Use of topical azathioprine and thioguanine to treat colorectal adenomas
|
US20040018236A1
(en)
*
|
1995-05-08 |
2004-01-29 |
Robert Gurny |
Nanoparticles for oral administration of pharmaceutical agents of low solubility
|
US5686106A
(en)
*
|
1995-05-17 |
1997-11-11 |
The Procter & Gamble Company |
Pharmaceutical dosage form for colonic delivery
|
US6156340A
(en)
*
|
1996-03-29 |
2000-12-05 |
Duquesne University Of The Holy Ghost |
Orally administrable time release drug containing products
|
AU2521797A
(en)
*
|
1996-04-12 |
1997-11-07 |
Japan Atomic Energy Research Institute |
Ph-sensitive polymers
|
GB9620709D0
(en)
*
|
1996-10-04 |
1996-11-20 |
Danbiosyst Uk |
Colonic delivery of weak acid drugs
|
DE19732903A1
(de)
|
1997-07-30 |
1999-02-04 |
Falk Pharma Gmbh |
Pellet-Formulierung zur Behandlung des Intestinaltraktes
|
EP1101490B1
(en)
|
1998-07-28 |
2005-04-13 |
Tanabe Seiyaku Co., Ltd. |
Preparation capable of releasing drug at target site in intestine
|
CA2344306A1
(en)
*
|
1998-09-21 |
2000-03-30 |
Amato Pharmaceutical Products, Ltd. |
Oral drug delivery system for enhancing the bioavailability of active form of glycyrrhizin
|
US20010055613A1
(en)
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
IT1303753B1
(it)
*
|
1998-11-13 |
2001-02-23 |
Ct Lab Farm Srl |
Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici.
|
AU764469B2
(en)
|
1999-01-29 |
2003-08-21 |
Disphar International B.V. |
Pharmaceutical compositions
|
JP2000247911A
(ja)
|
1999-02-26 |
2000-09-12 |
Hisamitsu Pharmaceut Co Inc |
大腸用吸収促進剤
|
US8895064B2
(en)
|
1999-06-14 |
2014-11-25 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
ATE251449T1
(de)
|
1999-06-14 |
2003-10-15 |
Cosmo Spa |
Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
|
IL130602A0
(en)
|
1999-06-22 |
2000-06-01 |
Dexcel Ltd |
Stable benzimidazole formulation
|
WO2001002014A1
(fr)
|
1999-07-02 |
2001-01-11 |
Hisamitsu Pharmaceutical Co., Inc. |
Compositions medicamenteuses destinees au traitement du cancer colorectal
|
US20030114349A1
(en)
*
|
2000-04-27 |
2003-06-19 |
The Procter & Gamble Company |
Coating composition for solid bodies
|
EP1294361B1
(en)
|
2000-06-21 |
2011-05-25 |
Cubist Pharmaceuticals, Inc. |
Compositions and methods to improve the oral absorption of antimicrobial agents
|
JP4163946B2
(ja)
|
2000-08-29 |
2008-10-08 |
バイオコン・リミテッド |
免疫調節性化合物およびその誘導体並びにそれを用いて疾患を治療する方法
|
CA2359812C
(en)
*
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
US20070059368A1
(en)
*
|
2005-05-31 |
2007-03-15 |
Cherukuri S R |
Modified release formulations of anti-irritability drugs
|
US8048924B2
(en)
|
2001-08-29 |
2011-11-01 |
Biocon Limited |
Methods and compositions employing 4-aminophenylacetic acid compounds
|
AR036797A1
(es)
|
2001-10-15 |
2004-10-06 |
Ferring Bv |
Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
|
JP2007523664A
(ja)
*
|
2003-04-23 |
2007-08-23 |
フェリング ベスローテン フェンノートシャップ |
医薬組成物用サシェ
|
EP1661574B1
(en)
|
2003-09-01 |
2017-04-19 |
Earthus, Inc. |
Beta-hydroxy short to medium chain fatty acid polymer
|
US7737133B2
(en)
*
|
2003-09-03 |
2010-06-15 |
Agi Therapeutics Ltd. |
Formulations and methods of treating inflammatory bowel disease
|
US7825106B2
(en)
|
2003-09-03 |
2010-11-02 |
Agi Therapeutics Ltd. |
Modified release formulations and methods of treating inflammatory bowel disease
|
CA2553775A1
(en)
*
|
2004-01-20 |
2005-08-11 |
Richard F. Harty |
Compositions and methods of treatment for inflammatory diseases
|
HUE029189T2
(en)
|
2004-02-06 |
2017-02-28 |
Pharmatel (R&D) Pty Ltd As Trustee For The Pharmatel (R & D) Trust |
The use of aminosalicylates in diarrhea prodominant irritable bowel syndrome
|
DE602005022175D1
(de)
*
|
2004-05-28 |
2010-08-19 |
Salix Pharmaceuticals Inc |
Prävention, behandlung und linderung strahlungsinduzierter enteritis
|
WO2006004795A2
(en)
|
2004-06-25 |
2006-01-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
ES2565848T3
(es)
|
2004-07-07 |
2016-04-07 |
Biocon Limited |
Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
|
KR101123001B1
(ko)
*
|
2004-09-01 |
2012-03-13 |
더 프록터 앤드 갬블 캄파니 |
5-아미노-2-하이드록시벤조산 및 환원당을 함유하는 조성물
|
US9149439B2
(en)
*
|
2005-03-21 |
2015-10-06 |
Sandoz Ag |
Multi-particulate, modified-release composition
|
US20090017110A1
(en)
*
|
2005-05-31 |
2009-01-15 |
Capricorn Pharma Inc. |
Modified release formulations of anti-irritability drugs
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
EP2529729A1
(en)
*
|
2005-08-24 |
2012-12-05 |
Salix Pharmaceuticals, Inc. |
Balsalazide formulations and manufacture thereof
|
US8921344B2
(en)
*
|
2006-11-03 |
2014-12-30 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
US7964215B1
(en)
|
2006-01-24 |
2011-06-21 |
Emet Pharmaceuticals, LLC |
Delayed release dosage form
|
GB0607534D0
(en)
*
|
2006-04-13 |
2006-05-24 |
Univ London Pharmacy |
Colonic drug delivery formulation
|
CA2653869A1
(en)
*
|
2006-06-06 |
2007-12-13 |
Antibe Therapeutics Inc. |
Salts of trimebutine and n-desmethyl trimebutine
|
AU2006348138A1
(en)
*
|
2006-09-13 |
2008-03-20 |
Warner Chilcott Company, Llc |
Methods of treatment for ulcerative colitis using aminosalicylate
|
WO2008033124A1
(en)
*
|
2006-09-13 |
2008-03-20 |
The Procter & Gamble Company |
Methods of treatment for ulcerative colitis
|
WO2008085484A2
(en)
*
|
2006-12-28 |
2008-07-17 |
Jacobus Pharmaceutical Company, Inc. |
Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid
|
US20090028944A1
(en)
*
|
2007-07-16 |
2009-01-29 |
Balaji Sathurappan |
Pharmaceutical compositions comprising mesalamine
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
US20090162434A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Disphar International Bv |
Mesalazine tablet
|
US20090169622A1
(en)
*
|
2007-12-27 |
2009-07-02 |
Roxane Laboratories, Inc. |
Delayed-release oral pharmaceutical composition for treatment of colonic disorders
|
EA022886B1
(ru)
*
|
2008-10-03 |
2016-03-31 |
Др. Фальк Фарма Гмбх |
Способ поддержания ремиссии язвенного колита у пациентов
|
EP2350012B1
(en)
|
2008-10-06 |
2017-06-28 |
The Johns Hopkins University |
Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
|
US9463163B2
(en)
|
2009-10-16 |
2016-10-11 |
Sun Pharmaceutical Industries Limited |
Delayed release pharmaceutical composition of mesalamine
|
US10154964B2
(en)
|
2011-09-07 |
2018-12-18 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
CN104302278B
(zh)
|
2012-03-29 |
2018-08-21 |
塞拉拜姆有限责任公司 |
在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂
|
US20140066837A1
(en)
|
2012-07-26 |
2014-03-06 |
Ronald L. Moy |
Skin care compositions and methods
|
US20140141075A1
(en)
|
2012-11-21 |
2014-05-22 |
Warner Chilcott Company, Llc |
5-aminosalicylic acid capsule formulation
|
CN105120847B
(zh)
|
2013-03-14 |
2018-12-28 |
塞拉拜姆有限责任公司 |
益生生物和/或治疗剂的靶向胃肠道递送
|
US9539265B2
(en)
|
2013-03-15 |
2017-01-10 |
Aihol Corporation |
Pharmaceutical formulation containing glycosaminoglycan
|
US9763887B2
(en)
|
2013-03-15 |
2017-09-19 |
Allergan Pharmaceuticals International Limited |
Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
|
KR102341899B1
(ko)
|
2013-04-07 |
2021-12-21 |
더 브로드 인스티튜트, 인코퍼레이티드 |
개인맞춤화 신생물 백신을 위한 조성물 및 방법
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
WO2015095811A2
(en)
|
2013-12-20 |
2015-06-25 |
The Board Institute Inc. |
Combination therapy with neoantigen vaccine
|
CA2902911C
(en)
|
2014-10-31 |
2017-06-27 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2016100975A1
(en)
|
2014-12-19 |
2016-06-23 |
Massachsetts Institute Ot Technology |
Molecular biomarkers for cancer immunotherapy
|
EP3757211A1
(en)
|
2014-12-19 |
2020-12-30 |
The Broad Institute, Inc. |
Methods for profiling the t-cell-receptor repertoire
|
KR20180010229A
(ko)
|
2015-05-20 |
2018-01-30 |
더 브로드 인스티튜트, 인코퍼레이티드 |
공유 신생항원
|
USD809116S1
(en)
|
2015-11-02 |
2018-01-30 |
Pura Scents |
Dispenser
|
CA3133703C
(en)
|
2015-11-02 |
2023-10-24 |
Pura Scents, Inc. |
Scent dispensation
|
USD816506S1
(en)
|
2015-11-02 |
2018-05-01 |
Pura Scents, Inc. |
Vial for a scent dispenser
|
AU2017254477A1
(en)
|
2016-04-18 |
2018-11-01 |
Jennifer G. ABELIN |
Improved HLA epitope prediction
|
EP3257501A1
(en)
|
2016-06-14 |
2017-12-20 |
Tillotts Pharma AG |
Multiple unit dosage form comprising a core with individual core units covered by a mucoadhesive material, and an enteric core coating
|
EP3574116A1
(en)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
US10098898B1
(en)
|
2017-12-04 |
2018-10-16 |
Handa Pharmaceuticals, Llc |
Release stable mesalamine dosage forms
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
AU2021280261A1
(en)
|
2020-05-26 |
2023-01-19 |
Dionis Therapeutics, Inc. |
Nucleic acid artificial mini-proteome libraries
|
WO2023076733A1
(en)
|
2021-11-01 |
2023-05-04 |
Dana-Farber Cancer Institute, Inc. |
Biologically selected nucleic acid artificial mini-proteome libraries
|